Table 3.
Quality of life, mental health, imaging examination and laboratory examinations of participants who completed 6-month, and 12-month follow-up.
| 6-month follow-up n = 105 |
12-month follow-up n = 105 |
P value | |
|---|---|---|---|
| mMRC score ≥1 | 38/93 (40.86) | 36/93 (38.71) | 0.764 |
| EQ-5D-5L questionnaire | |||
| Mobility problem | 8/93 (8.60) | 16/93 (17.20) | 0.080 |
| Personal care problem | 2/93 (2.15) | 5/93 (5.38) | 0.444 |
| Usual activity problem | 5/93 (5.38) | 7/93 (7.53) | 0.551 |
| Pain or discomfort | 48/93 (51.61) | 34/93 (35.56) | 0.039 |
| Anxiety or depression | 48/93 (51.61) | 43/93 (46.24) | 0.463 |
| EQ-VAS score | 75.65 ± 18.90 | 79.34 ± 19.01 | 0.187 |
| Anxiety symptom (GAD-7 ≥ 5) |
36/93 (38.71) | 32/93 (34.41) | 0.543 |
| Depression symptom (PHQ-9 ≥ 5) |
45/93 (48.39) | 39/93 (41.94) | 0.377 |
| PTSD symptom (PCL-C ≥ 38) |
18/93 (19.35) | 16/93 (17.20) | 0.704 |
| Chest CT | |||
| Normal CT pattern | 53/98 (54.08) | 51/98 (52.04) | 0.775 |
| Pleural thickening | 6/98 (6.12) | 5/98 (5.10) | 0.756 |
| Chronic slight inflammation | 19/98 (19.39) | 20/98 (20.41) | 0.858 |
| Interstitial change | 2/98 (2.04) | 2/98 (2.04) | 1.000 |
| Nodule | 19/98 (19.39) | 23/98 (23.47) | 0.486 |
| Old fibro lesions | 26/98(26.53) | 31/98 (31.63) | 0.432 |
| Laboratory examinations | |||
| White blood cell count >9.5, 10^9/L | 2/105 (1.90) | 4/105 (3.81) | 0.683 |
| Haemoglobin <90, g/L | 5/105 (4.76) | 1/105 (0.95) | 0.212 |
| Neutrophils count >6.3, 10^9/L | 4/105 (3.81) | 3/105 (2.86) | 0.701 |
| Lymphocyte count <1.1, 10^9/L | 3/105 (2.86) | 2/105 (1.90) | 0.651 |
| Platelet <125, 10^9/L | 2/105 (1.90) | 1/105 (0.95) | 0.561 |
| NT-Pro-BNP >125, pg/ml | 1/105 (0.95) | 5/105 (4.76) | 0.212 |
| C-reactive ptotein >5, mg/L | 4/105 (3.81) | 9/105 (8.57) | 0.152 |
| Alanine aminotransferase >2UL, U/L | 4/105 (15.24) | 3/105 (13.33) | 0.701 |
| Aspartate aminotransferase >2UL, U/L | 1/105 (8.57) | 3/105 (6.67) | 0.621 |
| Total bilirubin >2UL, μmol/L | 0/105 (5.71) | 0/105 (3.81) | NA |
| Glomeruar filtration rate <90, ml/min | 23/105 (21.90) | 32/105 (30.48) | 0.158 |